BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26220878)

  • 1. Ramelteon as adjunctive therapy for delirium referred to a consultation-liaison psychiatry service: a retrospective analysis.
    Furuya M; Miyaoka T; Yasuda H; Wake R; Hashioka S; Miura S; Nagahama M; Araki T; Horiguchi J
    Int J Geriatr Psychiatry; 2015 Sep; 30(9):994-5. PubMed ID: 26220878
    [No Abstract]   [Full Text] [Related]  

  • 2. Successfully treated delirium in an extremely elderly patient by switching from risperidone to ramelteon.
    Tsuda A; Nishimura K; Naganawa E; Otsubo T; Ishigooka J
    Psychiatry Clin Neurosci; 2013 Feb; 67(2):130. PubMed ID: 23438172
    [No Abstract]   [Full Text] [Related]  

  • 3. Ramelteon for the treatment of delirium in elderly patients: a consecutive case series study.
    Tsuda A; Nishimura K; Naganawa E; Otsubo T; Ishigooka J
    Int J Psychiatry Med; 2014; 47(2):97-104. PubMed ID: 25084796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin receptor agonists for treating delirium in elderly patients with acute stroke.
    Ohta T; Murao K; Miyake K; Takemoto K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1107-10. PubMed ID: 23017429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Ramelteon in Reduction of As-Needed Antipsychotics in Elderly Patients with Delirium in a General Hospital Setting.
    Pinkhasov A; James SA; Fazzari M; Singh D; Lam S
    Clin Drug Investig; 2017 Dec; 37(12):1137-1141. PubMed ID: 28933013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin Receptor Agonists for Delirium Prevention.
    Walker CK; Gales MA
    Ann Pharmacother; 2017 Jan; 51(1):72-78. PubMed ID: 27539735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19639675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked improvement in delirium with ramelteon: five case reports.
    Furuya M; Miyaoka T; Yasuda H; Yamashita S; Tanaka I; Otsuka S; Wake R; Horiguchi J
    Psychogeriatrics; 2012 Dec; 12(4):259-62. PubMed ID: 23279149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putting insomnia to rest.
    Holcomb SS
    Nurse Pract; 2007 Apr; 32(4):28-34; quiz 34-5. PubMed ID: 17414828
    [No Abstract]   [Full Text] [Related]  

  • 10. [Delirium, insomnia in hospitalization and ramelteon].
    Ito T
    Nihon Rinsho; 2012 May; 70(5):907-13. PubMed ID: 22620020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of delirium with ramelteon: initial experience in three patients.
    Kimura R; Mori K; Kumazaki H; Yanagida M; Taguchi S; Matsunaga H
    Gen Hosp Psychiatry; 2011; 33(4):407-9. PubMed ID: 21762839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Therapy With Ramelteon for Hypoactive Delirium: A Case Report.
    Miura S; Furuya M; Yasuda H; Miyaoka T; Horiguchi J
    J Clin Psychopharmacol; 2015 Oct; 35(5):616-8. PubMed ID: 26114404
    [No Abstract]   [Full Text] [Related]  

  • 13. Melatonin and Ramelteon for the treatment of delirium: A systematic review and meta-analysis.
    Beaucage-Charron J; Rinfret J; Coveney R; Williamson D
    J Psychosom Res; 2023 Jul; 170():111345. PubMed ID: 37150157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive treatment with melatonin receptor agonists for older delirious patients with the sundowning phenomenon.
    Yeh TC; Yeh CB; Tzeng NS; Mao WC
    J Psychiatry Neurosci; 2015 Mar; 40(2):E25-6. PubMed ID: 25703643
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of delirium in the elderly].
    Ranhoff AH
    Tidsskr Nor Laegeforen; 2004 Dec; 124(23):3072-4. PubMed ID: 15586192
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
    Spadoni G; Bedini A; Lucarini S; Mor M; Rivara S
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Use of Ramelteon for Delirium in Hospitalized Patients: A Systematic Review and Meta-Analyses.
    Dang V; Mansukhani MP; Wang Z; Kinzelman Vesely E; Kolla BP
    J Acad Consult Liaison Psychiatry; 2023; 64(1):65-72. PubMed ID: 35718086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramelteon is Not Associated With Improved Outcomes Among Critically Ill Delirious Patients: A Single-Center Retrospective Cohort Study.
    Thom R; Bui M; Rosner B; Teslyar P; Levy-Carrick N; Wolfe D; Klompas M
    Psychosomatics; 2019; 60(3):289-297. PubMed ID: 30193784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin based therapies for delirium and dementia.
    Alagiakrishnan K
    Discov Med; 2016 May; 21(117):363-71. PubMed ID: 27355332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance].
    Mishima K
    Nihon Rinsho; 2012 Jun; 70(6):1069-78. PubMed ID: 22690618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.